Skip to content

ProteoTech

Startup thumbnail placeholder image

Description

ProteoTech is developing innovative treatments for amyloid diseases and misfolded protein disorders.

Team Members

Alan Snow, President

Chief Scientific Officer, and Co-founder; formerly Research Professor of Pathology, University of Washington

Roger Flugel

CEO